[144] Warby Parker Inc. SEC Filing

Rhea-AI Filing Summary

Warby Parker Inc. Form 144: This filing discloses a proposed sale of 50,000 common shares on or about 08/13/2025 through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $1,220,500.00. The shares were acquired on 12/04/2019 through previously exercised stock options and were paid in cash. The company’s outstanding share count is reported as 105,187,778, so the proposed sale represents roughly 0.05% of outstanding common shares.

The filing also lists two recent Rule 10b5-1 sales by the same account in July 2025: 49,600 shares on 07/21/2025 for $1,200,786.24 and 400 shares on 07/18/2025 for $9,604.00. The filer affirms the standard representation about lack of undisclosed material adverse information.

Positive

• Transaction disclosed under Rule 144/10b5-1 providing transparency around insider sales
• Details provided on acquisition date and method (12/04/2019 via exercised stock options), enabling clear provenance of shares

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine, pre-arranged insider sale disclosed under Rule 144/10b5-1 with negligible size relative to outstanding shares.

The filing shows a proposed sale of 50,000 common shares by the account linked to Neil Harris Blumenthal, acquired via exercised options in 2019. The sale is to be executed through Morgan Stanley on the NYSE and is reported alongside July 2025 10b5-1 sales totaling 50,000 shares. At ~0.05% of the company's 105,187,778 outstanding shares, this transaction is immaterial to capital structure. Disclosure complies with Form 144 requirements and includes the standard issuer-information representation.

Securities Analyst

TL;DR: Insider sales documented and transparent; size and recent sale history suggest routine liquidity, not a material market event.

The aggregate market value for the proposed 50,000-share sale is listed as $1,220,500.00. The filer previously sold 49,600 and 400 shares in July 2025 for $1,200,786.24 and $9,604.00 respectively, indicating execution under an established 10b5-1 plan. Given the acquisition date of 12/04/2019 and payment in cash, these are post-vesting option dispositions. From a market-impact perspective, the volumes are small relative to outstanding shares and unlikely to affect valuation materially.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	1220500.00	105187778	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/04/2019	Previously Exercised Stock Options	Issuer			50000	12/04/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NEIL HARRIS BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	COMMON	07/21/2025	49600	1200786.24
10b5-1 Sales for NEIL HARRIS BLUMENTHAL 233 Spring Street, 6th Floor East New York NY 10013	COMMON	07/18/2025	400	9604.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the WRBY Form 144 disclose?

The filing discloses a proposed sale of 50,000 Warby Parker common shares with an aggregate market value of $1,220,500.00, to be executed around 08/13/2025 on the NYSE.

Who is the seller named in the filing for WRBY?

The recent sales rows identify Neil Harris Blumenthal as the account associated with prior 10b5-1 sales; the Form 144 lists the proposed sale tied to that account.

How were the 50,000 shares acquired?

The shares were acquired on 12/04/2019 through previously exercised stock options and paid for in cash.

Have there been related sales in the past three months?

Yes. The filing lists two 10b5-1 sales in July 2025: 49,600 shares on 07/21/2025 for $1,200,786.24 and 400 shares on 07/18/2025 for $9,604.00.

Which broker is handling the proposed sale for WRBY?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE.

What portion of Warby Parker’s outstanding shares does this sale represent?

The company’s outstanding share count is reported as 105,187,778, so the 50,000-share sale represents approximately 0.05% of outstanding common shares.